These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism. Fichera A; Guo Y; Romero L; Michelassi F; Arenas RB J Surg Res; 1997 Apr; 69(1):188-92. PubMed ID: 9202668 [TBL] [Abstract][Full Text] [Related]
3. Apc mice: models, modifiers and mutants. McCart AE; Vickaryous NK; Silver A Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487 [TBL] [Abstract][Full Text] [Related]
4. Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis. De Rosa M; Galatola M; Borriello S; Duraturo F; Masone S; Izzo P Dis Colon Rectum; 2009 Feb; 52(2):268-74. PubMed ID: 19279422 [TBL] [Abstract][Full Text] [Related]
5. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression. Yekkala K; Baudino TA Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel duplication in the APC gene using multiple ligation probe amplification in a patient with familial adenomatous polyposis. Pedace L; Majore S; Megiorni F; Binni F; De Bernardo C; Antigoni I; Preziosi N; Mazzilli MC; Grammatico P Cancer Genet Cytogenet; 2008 Apr; 182(2):130-5. PubMed ID: 18406876 [TBL] [Abstract][Full Text] [Related]
8. Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Bright-Thomas RM; Agrawal A; Hargest R Br J Surg; 2002 Dec; 89(12):1563-9. PubMed ID: 12445067 [TBL] [Abstract][Full Text] [Related]
9. Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis. Yang K; Edelmann W; Fan K; Lau K; Leung D; Newmark H; Kucherlapati R; Lipkin M Cancer Res; 1998 Dec; 58(24):5713-7. PubMed ID: 9865728 [TBL] [Abstract][Full Text] [Related]
10. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Watson SA; Smith AM Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260 [TBL] [Abstract][Full Text] [Related]
11. Mutational screening of the APC gene in Chilean families with familial adenomatous polyposis: nine novel truncating mutations. De la Fuente MK; Alvarez KP; Letelier AJ; Bellolio F; Acuña ML; León FS; Pinto E; Carvallo P; López-Köstner F Dis Colon Rectum; 2007 Dec; 50(12):2142-8. PubMed ID: 17963004 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse. Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222 [TBL] [Abstract][Full Text] [Related]
13. APC in the regulation of intestinal crypt fission. Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477 [TBL] [Abstract][Full Text] [Related]
14. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer. Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093 [TBL] [Abstract][Full Text] [Related]
15. Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis. Uckun FM; Erbeck D; Qazi S; Venkatachalam T; Tibbles HE; Vassilev A Arzneimittelforschung; 2007; 57(6):320-9. PubMed ID: 17688077 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of both APC alleles in human and mouse tumors. Levy DB; Smith KJ; Beazer-Barclay Y; Hamilton SR; Vogelstein B; Kinzler KW Cancer Res; 1994 Nov; 54(22):5953-8. PubMed ID: 7954428 [TBL] [Abstract][Full Text] [Related]
17. Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis. Mutoh M; Akasu T; Takahashi M; Niho N; Yoshida T; Sugimura T; Wakabayashi K Jpn J Clin Oncol; 2006 Mar; 36(3):166-71. PubMed ID: 16478792 [TBL] [Abstract][Full Text] [Related]
18. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Li Q; Ishikawa TO; Oshima M; Taketo MM Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028 [TBL] [Abstract][Full Text] [Related]
19. Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis. Valanzano R; Ficari F; Curia MC; Aceto G; Veschi S; Cama A; Battista P; Tonelli F J Surg Oncol; 2007 Jan; 95(1):28-33. PubMed ID: 17192888 [TBL] [Abstract][Full Text] [Related]
20. Detection of APC gene deletion by double competitive polymerase chain reaction in patients with familial adenomatous polyposis. Takahashi M; Kikuchi M; Ohkura N; Yaguchi H; Nagamura Y; Ohnami S; Ushiama M; Yoshida T; Sugano K; Iwama T; Kosugi S; Tsukada T Int J Oncol; 2006 Aug; 29(2):413-21. PubMed ID: 16820884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]